316 related articles for article (PubMed ID: 37719380)
1. Research advances in peptide‒drug conjugates.
Gong L; Zhao H; Liu Y; Wu H; Liu C; Chang S; Chen L; Jin M; Wang Q; Gao Z; Huang W
Acta Pharm Sin B; 2023 Sep; 13(9):3659-3677. PubMed ID: 37719380
[TBL] [Abstract][Full Text] [Related]
2. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic.
Rizvi SFA; Zhang L; Zhang H; Fang Q
ACS Pharmacol Transl Sci; 2024 Feb; 7(2):309-334. PubMed ID: 38357281
[TBL] [Abstract][Full Text] [Related]
3. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel.
Wang L; Chen H; Wang F; Zhang X
Expert Opin Drug Deliv; 2022 Feb; 19(2):147-161. PubMed ID: 35130795
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
5. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Fu C; Yu L; Miao Y; Liu X; Yu Z; Wei M
Acta Pharm Sin B; 2023 Feb; 13(2):498-516. PubMed ID: 36873165
[TBL] [Abstract][Full Text] [Related]
6. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
[TBL] [Abstract][Full Text] [Related]
7. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
Alas M; Saghaeidehkordi A; Kaur K
J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
[TBL] [Abstract][Full Text] [Related]
8. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
Zhou L; Lu Y; Liu W; Wang S; Wang L; Zheng P; Zi G; Liu H; Liu W; Wei S
Exp Hematol Oncol; 2024 Mar; 13(1):26. PubMed ID: 38429828
[TBL] [Abstract][Full Text] [Related]
9. Peptide Drug Conjugates and Their Role in Cancer Therapy.
Heh E; Allen J; Ramirez F; Lovasz D; Fernandez L; Hogg T; Riva H; Holland N; Chacon J
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614268
[TBL] [Abstract][Full Text] [Related]
10. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
[TBL] [Abstract][Full Text] [Related]
11. Advances in peptide-based drug delivery systems.
Guo S; Wang J; Wang Q; Wang J; Qin S; Li W
Heliyon; 2024 Feb; 10(4):e26009. PubMed ID: 38404797
[TBL] [Abstract][Full Text] [Related]
12. Engineering peptide drug therapeutics through chemical conjugation and implication in clinics.
Rizvi SFA; Zhang H; Fang Q
Med Res Rev; 2024 May; ():. PubMed ID: 38704826
[TBL] [Abstract][Full Text] [Related]
13. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
Cooper BM; Iegre J; O' Donovan DH; Ölwegård Halvarsson M; Spring DR
Chem Soc Rev; 2021 Feb; 50(3):1480-1494. PubMed ID: 33346298
[TBL] [Abstract][Full Text] [Related]
14. Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.
Vrettos EI; Karampelas T; Sayyad N; Kougioumtzi A; Syed N; Crook T; Murphy C; Tamvakopoulos C; Tzakos AG
Eur J Med Chem; 2021 Feb; 211():113018. PubMed ID: 33223264
[TBL] [Abstract][Full Text] [Related]
15. Peptide-drug conjugate-based novel molecular drug delivery system in cancer.
Zhu YS; Tang K; Lv J
Trends Pharmacol Sci; 2021 Oct; 42(10):857-869. PubMed ID: 34334251
[TBL] [Abstract][Full Text] [Related]
16. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
[TBL] [Abstract][Full Text] [Related]
17. Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.
Sheyi R; de la Torre BG; Albericio F
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214128
[TBL] [Abstract][Full Text] [Related]
18. Peptide-Drug Conjugate: A Novel Drug Design Approach.
Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
[TBL] [Abstract][Full Text] [Related]
19. Peptide cargo administration: current state and applications.
Rohira H; Arora A; Kaur P; Chugh A
Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
[TBL] [Abstract][Full Text] [Related]
20. Construction of Peptide-Drug Conjugates for Selective Targeting of Malignant Tumor Cells.
Vrettos EI; Tzakos AG
Methods Mol Biol; 2021; 2207():327-338. PubMed ID: 33113145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
